Publication | Closed Access

An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia

Developmental BiologyFertilityAmniotic FluidGynecologyPregnancyMaternal HealthMid-trimester Genetic AmniocentesisMaternal-fetal MedicinePublic HealthFetal ComplicationMedicineElevated Maternal PlasmaPreeclampsiaHigh-risk Pregnancy